Banque Pictet & Cie’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$675K Hold
1,282
﹤0.01% 255
2026
Q1
$720K Sell
1,282
-918
-42% -$589K 0.01% 292
2025
Q4
$1.49M Hold
2,200
0.01% 236
2025
Q3
$1.41M Hold
2,200
0.01% 246
2025
Q2
$1.18M Sell
2,200
-380
-15% -$182K 0.01% 242
2025
Q1
$1.08M Sell
2,580
-458
-15% -$199K 0.01% 247
2024
Q4
$1.26M Sell
3,038
-535
-15% -$235K 0.01% 235
2024
Q3
$1.81M Buy
3,573
+880
+33% +$428K 0.01% 199
2024
Q2
$1.31M Hold
2,693
0.01% 212
2024
Q1
$1.45M Sell
2,693
-570
-17% -$312K 0.01% 213
2023
Q4
$1.81M Sell
3,263
-2,737
-46% -$1.28M 0.02% 206
2023
Q3
$2.62M Buy
6,000
+704
+13% +$351K 0.03% 186
2023
Q2
$2.66M Buy
5,296
+458
+9% +$219K 0.02% 217
2023
Q1
$2.42M Buy
4,838
+350
+8% +$167K 0.02% 247
2022
Q4
$1.83M Buy
4,488
+483
+12% +$187K 0.02% 302
2022
Q3
$1.3M Sell
4,005
-34,742
-90% -$12.8M 0.01% 356
2022
Q2
$13.6K Buy
38,747
+4,672
+14% +$1.91M 0.13% 85
2022
Q1
$18.6M Sell
34,075
-842
-2% -$443K 0.14% 82
2021
Q4
$23M Sell
34,917
-4,190
-11% -$2.63M 0.17% 72
2021
Q3
$24.3M Sell
39,107
-1,144
-3% -$769K 0.25% 59
2021
Q2
$25.4M Sell
40,251
-6,810
-14% -$3.76M 0.28% 53
2021
Q1
$23M Buy
47,061
+269
+0.6% +$135K 0.3% 49
2020
Q4
$23.4M Buy
46,792
+2,015
+5% +$902K 0.32% 48
2020
Q3
$17.6M Sell
44,777
-4,670
-9% -$1.73M 0.27% 52
2020
Q2
$16.3M Sell
49,447
-1,670
-3% -$484K 0.27% 49
2020
Q1
$12.4M Buy
51,117
+10,606
+26% +$2.77M 0.25% 51
2019
Q4
$10.6M Hold
40,511
0.18% 83
2019
Q3
$11M Sell
40,511
-2,785
-6% -$775K 0.21% 71
2019
Q2
$11.9M Sell
43,296
-2,539
-6% -$626K 0.22% 62
2019
Q1
$10.2M Buy
45,835
+6,220
+16% +$1.28M 0.2% 73
2018
Q4
$7.37M Buy
39,615
+38,380
+3,108% +$7.87M 0.15% 99
2018
Q3
$308K Hold
1,235
0.01% 323
2018
Q2
$269K Hold
1,235
0.01% 324
2018
Q1
$236K Buy
+1,235
New +$228K 0.01% 342

Other funds holding IDXX

Banque Pictet & Cie's IDXX Position: Q2 2026 in Review

Banque Pictet & Cie held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 1,282 shares worth $675K. The position accounts for ﹤0.01% of the portfolio, ranked #255.

Banque Pictet & Cie first reported a position in IDXX in Q1 2018 and has held it in 34 quarters since. The position peaked at $25.4M in Q2 2021. 330 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Banque Pictet & Cie held 1,282 shares of Idexx Laboratories worth $675K as of Q2 2026.
  • Banque Pictet & Cie left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of Banque Pictet & Cie's portfolio in Q2 2026, its #255 holding.
  • Banque Pictet & Cie first reported a position in Idexx Laboratories in Q1 2018 and has held it in 34 quarters since.
  • Banque Pictet & Cie's Idexx Laboratories position peaked at $25.4M in Q2 2021.
  • 330 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.